SSTR4 agonist 2
SSTR4 agonist 2 is a potent agonist of somatostatin receptor subtype 4 (SSTR4) . SSTR4 pathway inhibits nociceptive and inflammatory processes. SSTR4 agonist 2 has the potential for the research of medical disorders related to SSTR4 (extracted from patent WO2014184275A1, compound 107) [1].
Product Specifications
CAS Number
[1638589-52-2]
UNSPSC
12352005
Target
Somatostatin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sstr4-agonist-2.html
Purity
99.3900
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C)(C(C1=CC=C2)=NN(C)C1=C2C)NC([C@H]3[C@@]4([H])[C@]3([H])CNC4)=O
Molecular Formula
C18H24N4O
Molecular Weight
312.41
References & Citations
[1]Riccardo Giovannini, et al. New somatostatin receptor subtype 4 (sstr4) agonists. Patent WO2014184275A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Androgen Receptor Protein (AR, DHTR, NR3C4, Androgen receptor, Dihydrotestosterone receptor, Nuclear receptor subfamily 3 group C member 4)
Fetoprotein, Alpha (Alpha Fetoprotein, Alpha, Alpha-fetoprotein Precursor, AFP, Alpha-1-fetoprotein, Alpha-fetoglobulin, FETA, HPAFP) (HRP) discontinued